You just read:

Astellas and Seattle Genetics Present ASG-15ME and ASG-22ME Phase I Clinical Data in Metastatic Urothelial Cancer at ASCO Annual Meeting

News provided by

Astellas Pharma Inc.

Jun 06, 2016, 08:00 ET